NOTICIAS BREVES





  Noticias Breves julio 29-2013

 
JORNADA CIENTÍTICA ON LINE AAHI



31 de julio de 2013


Seguridad del Paciente y Manejo del error médico
Lic. Ariel Palacios. Jefe de Seguridad del paciente Htal. Universitario Austral

Lugar: Aula Magna del Hospital Fernández (Cerviño 3356, piso 3, Ciudad de Buenos Aires)
Horario: 19 a 21 h. (Hora de Buenos Aires GM -3).

Clic aquí para acceder a esta Reunión Científica online

------------------------------------------------------------------------------------------------------------------------
Noticias Breves julio 26-2013
 
 
 

Tragedia de Santiago de Compostela – Galicia - España

 
Con profundo pesar por la tragedia sufrida por nuestros hermanos de España, hacemos llegar desde el GCIAMT nuestras condolencias y oraciones por el eterno descanso de las almas fallecidas y la pronta recuperación de los heridos. Que las familias de todos los damnificados encuentren paz y consolación en estos momentos de profundo dolor.
 

Materia compartido por nuestros miembros

 
En esta edición acercamos el Weekly Reporte de la AABB compartido por el Dr. César Cerdas-Quesada, Especialista Inmunohematología y Banco de Sangre, Universidad de Costa Rica, a quien agradecemos sus aportes.
 
 
 
 
Visit aabb.org Unsubscribe to this Newsletter
July 26, 2013 | Vol. 19 | No. 25
 

IN THIS ISSUE

 

AABB Issues Association Bulletin Updating Recommendations for HAV Common Source Outbreaks

The AABB Board of Directors has approved recommendations of the AABB Transfusion Transmitted Diseases Committee that address criteria for donor deferral and blood component retrieval in known or suspected common source outbreaks of hepatitis A virus, or HAV, infection. Published in Association Bulletin #13-03, the revisions update previous recommendations for postexposure prophylaxis, or PEP, and management of potentially HAV-infected donors and blood components. The bulletin offers guidance for blood collection facilities about maintaining communication with public health authorities to ensure the institutions remain informed of potential outbreaks and the need for PEP. Additionally, the document provides information related to implementing procedures in response to common source outbreaks, and identifying and managing donors who may have been exposed to HAV. The 2013 recommendations revise the preferred method of HAV PEP from immune globulin to the HAV vaccine and describe actions to be taken after recipients of potentially HAV-infected blood are discovered. AABB now suggests deferral of any donor who may have been exposed to an HAV outbreak regardless of reported vaccination status. The document also includes current HAV incidence rates as well as relevant links to the U.S. Centers for Disease Control and Prevention website.
This bulletin supersedes Association Bulletin #04-08, which was released following an HAV outbreak in Ohio in 2004 that affected 600 people. Release of the revised recommendations concurs with an ongoing investigation into an HAV outbreak — linked to both organic frozen berry blend and organic frozen pomegranate seeds — that has infected more than 150 people in eight states and was reported in this publication on June 7, 2013.

FDA Publishes Guidance on IND Requirements for the Use of Fecal Microbiota

The Food and Drug Administration announced a guidance for industry titled "Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat C. difficile Infection Not Responsive to Standard Therapies" in a "Federal Register" notice dated July 18. The document relates to investigational new drug, or IND, requirements for the use of fecal microbiota for transplantation, or FMT, to treat Clostridium difficile. The guidance explains that the FDA will exercise enforcement discretion of the IND requirements when physicians seeking to use FMT to treat C. difficile — that is unresponsive to standard therapies — obtain an adequate letter of informed consent from the patient or the affected individual's legally authorized representative. At a minimum, the informed consent should state that this use of FMT products is investigational and describe the potential risks of the treatment. The guidance does not pertain to other uses of FMT and the policies it contains only are in effect while FDA continues to consider applicable IND requirements. This guidance should be implemented immediately.
The FDA's Center for Biologics Evaluation and Research held a public workshop May 2-3 titled "Fecal Microbiota for Transplantation" and afforded scientists and physicians the opportunity to discuss concerns about the FDA's IND requirements for FMT. The FDA's response to comments made at that workshop was announced in this publication on June 21.

CBER Announces Meeting to Discuss Standards for Cellular Therapies and Regenerative Medicine

FDA's Center for Biologics Evaluation and Research announced in a July 22 "Federal Register" notice a public workshop titled "Synergizing Efforts in Standards Development for Cellular Therapies and Regenerative Medicine Products" that will be held Oct. 7 from 8:30 am - 4:30 pm at the FDA in Silver Spring, Md. The workshop will focus on cellular therapies, or CT, and regenerative medicine, covering topics that include the types of standards and standards organizations that currently exist, standards development as well as their regulatory application, and ways to minimize repetition and maximize collaboration when writing standards for both fields. Additionally, the workshop will allow time for discussion of high-interest subjects associated with standards development for CT and regenerative medicine. Individuals should register to attend by Sept. 23 as seating is limited; streaming of the public workshop webcast also is available.

FDA Posts Notice of Cellular, Tissue and Gene Therapies Advisory Committee Meeting

The FDA posted information about the next Cellular, Tissue and Gene Therapies Advisory Committee meeting that will be held Oct. 22-23 from 8:00 am - 5:30 pm, in Silver Spring, Md. During this meeting, which is open to the public, the committee will discuss topics that include oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease or treatment of infertility and updates on guidance documents from the Office of Cellular, Tissue and Gene Therapies; the Center for Biologics Evaluation and Research, or CBER; and the FDA. Additionally, the meeting will cover considerations for the design of early-phase clinical trials of cellular and gene therapy products — a topic that also will be the focus of a guidance that CBER intends to release later this year. Individuals interested in presenting written opinions or information should send in requests by Oct. 15; participants seeking to make oral statements explaining data or arguments should submit applications by Oct. 7.

The July Issue of 'AABB News' Explores Using Patient-Centric Data Metrics to Improve Care

The July issue of "AABB News" explores the role of patient-centered outcomes-based research — which incorporates metrics such as survival, health-related quality of life and severity of symptoms — in helping improve care at the bedside. Several outcomes-based studies are examined in detail within this issue. Additionally, one article highlights a provision of the Affordable Care Act that requires any hospital with more than 50 beds to have a contract with a patient safety organization, such as the AABB Center for Patient Safety. Also included in the issue — mailed this week to members — are pieces written by experts that examine the abbreviated donor history questionnaire and the 2013 American Society for Apheresis Guidelines on the use of therapeutic apheresis in clinical practice.

AABB PBM Webinar in August Addresses Coagulation Management

An AABB patient blood management, or PBM, webinar on coagulation management will be held Aug. 8. This second session in the 2013-14 PBM webinar series will describe the laboratory assessment of hemostatic function and provide guidance in determining the clinical interpretation of coagulation function. Additionally, the webinar will identify the optimal therapeutic options based upon these assessments.
Individuals may purchase all eight webinars of the series as a package to save nearly $90. Non-members may become members for additional savings of more than $150.

Upcoming AABB Webinar Highlights Cleaning and Disinfecting Cellular Therapy Facilities

An AABB webinar to be held Aug. 20 will explore current regulations and recommendations related to cleaning and sanitizing cellular therapy manufacturing sites. The webinar will describe common cleaners and disinfectants and the elements those products should contain. Additionally, the session will explain methods to validate product effectiveness against possible pathogens as well as offer examples of appropriate cleaning practices and procedures for various surfaces.

Reminder: AABB Audioconference Focuses on Factors That Regulate Red Cell Alloimmunization

An audioconference titled "Factors That Regulate Red Cell Alloimmunization: Lessons From Animal Models" will be held July 31 and will describe the function of the immune system relative to red cell alloimmunization. Two researchers — James Zimring, MD, PhD, and Jeanne Hendrickson, MD — will review the factors that affect red cell alloimmunization as well as those related to blood donor biology that may affect patient sensitization to red cells. Additionally, the speakers will explain how this information will affect the practice of human transfusion.
Zimring and Hendrickson are former National Blood Foundation, or NBF, grant recipients; additionally, Zimring serves as chair of the NBF Grants Review Committee and Hendrickson is an NBF Research and Education Trust board member.

Reminder: AABB Offers Preconvention Workshops on Cellular Therapy Products and PBM at the 2013 Annual Meeting & CTTXPO

Members can register for two workshops — focusing on the preservation of cellular therapy products and best practices in patient blood management, or PBM — when signing up for AABB's 2013 Annual Meeting and CTTXPO. A joint workshop that will be conducted by AABB and BioCoR, "The Preservation of Cellular Therapy Products: An In-Depth Collaborative Workshop," will explore the challenge of cryopreserving cellular therapy products. This two-day workshop, held Oct. 10-11, will investigate topics that include the physical and chemical changes of cellular therapy products during freezing, methods of protecting cells and the mechanisms of cell damage during freezing, and fundamentals of quality systems for cellular therapy.
"Patient Blood Management: Patient Care and Outcomes Strategies Workshop," a one-day workshop to be held Oct. 11, will focus on applying the concept of best practices in PBM programs. The workshop speakers will discuss preparing patients for an invasive procedure using the latest PBM strategies and describe research on the use of blood components when treating an upper gastrointestinal bleed. Additionally, the session will include a review of data compiled in the 2011 National Blood Collection and Utilization Survey.
The cellular therapy and PBM workshops require an additional fee.

Region Watch

According to the National Blood Exchange, most types of red blood cells, or RBCs, are plentiful and known needs are being met immediately. Compared with other blood products, AB plasma and O-negative RBCs are in highest demand nationwide and fulfilling requests for them takes nearly one week. The usage of single-bag cryoprecipitate exceeds availability as many blood centers are focusing on producing pooled cryoprecipitate instead of single-bag units. Levels of platelet products are satisfactory and all known needs are being met.
AABB, 8101 Glenbrook Road, Bethesda, MD 20814
+1.301.907.6977
Managing Editor: Jennifer Garfinkel
Copyright 2013 AABB. All rights reserved.
 

---------------------------------------------------------------------------------------------------------------------
Noticias Breves julio 25-2013

 

En esta edición acercamos la síntesis del Curso  de la Dra. Jorgelina Blejer acerca del desarrollo del Curso de Formación para el Desempeño de Bioquímicos y Biólogos en Servicios de Hemoterapia y Bancos de Sangre de la Asociación Argentina de Hemoterapia e Inmunohematología.

 

El informe completo se encontrará disponible en el próximo número impreso del Boletín del GCIAMT en la Revista.

 

 
CURSO DE FORMACIÓN PARA EL DESEMPEÑO DE BIOQUÍMICOS Y BIÓLOGOS EN SERVICIOS DE HEMOTERAPIA Y BANCOS DE SANGRE

 

El curso se dicta los últimos jueves y viernes de cada mes lectivo, de  8 a 12 horas y de 13,30 a 17,30 horas. Se adoptó esta modalidad para facilitar la concurrencia de profesionales del interior del país.

Además de clases presenciales, se realizan Talleres (secos y húmedos). Además, los alumnos presentan Seminarios a partir de trabajos científicos y Posters con resultados de sus lugares de trabajo.

Por otra parte, deben cumplir con rotaciones por diferentes Servicios donde participan en los temas de Tamizaje Serológico, Biología Molecular (NAT) e Inmunohematología.

La evaluación consta de tres exámenes parciales con 25 preguntas, la modalidad es opción múltiple de la cual deben responder correctamente el 60%, un examen final con la misma modalidad con 100 preguntas, se ponderan además notas de seminarios, posters y rotaciones.

La Directora es la Dra. Jorgelina L. Blejer y los docentes son Bioquímicos y Biólogos especialistas en Bancos de Sangre (Dr. Alejandro Chiera, Dra. Beatriz Livellara, Dr. José Magariños, Dra. Mirta Remesar, Dr. Jorge Rey, Dr. Sebastián Oknaian) así como Médicos de la AAHI, y profesionales de diversas disciplinas de instituciones como Facultad de Medicina, UBA, Facultad de Ciencias Exactas, UBA, Facultad de Farmacia y Bioquímica, UBA, Instituto Malbrán, CEMIC, Fundación Favaloro, Academia Nacional de Medicina, Centro Nacional de Referencia de Retrovirus, Instituto Nacional de Enfermedades Virales Humanas, entre otros.

 

El primer curso dictado  tuvo lugar entre agosto de 2010 y julio de 2012. La cantidad de inscriptos fue de 34 alumnos y 3 de ellos debieron discontinuarlo por razones personales antes del primer parcial. Posteriormente se inscribieron dos alumnos más. Todos ellos aprobaron el curso con muy buenas calificaciones.

 

El curso actual comenzó en agosto de 2012. Se han inscripto 25 alumnos, 10 de Capital Federal y el resto del interior del país y se está desarrollando con absoluta normalidad.

 

Dra. Jorgelina Blejer.
Directora del Curso

--------------------------------------------------------------------------------------------------------------------------
Noticias Breves julio 24-2013

 

En esta edición acercamos el boletín de nuestro miembro institucional la Asociación Argentina de Hemoterapia e Inmunohematología (AAHI)

 

Una vez más, nos ponemos en contacto con nuestros Asociados para hacerles llegar las últimas novedades relacionadas con nuestra disciplina:

-------------------------------------------------------------------------------------------------------------------------

Reunión Científica 31 de julio 2013

Seguridad del Paciente y Manejo del error médico
Lic. Ariel Palacios. Jefe de Seguridad del paciente H Universitario Austral

Lugar: Aula Magna del Hospital Fernández (Cerviño 3356, piso 3, Ciudad de Buenos Aires)
Horario: 19 a 21 hs.

Click aquí para acceder a esta Reunión Científica online

-------------------------------------------------------------------------------------------------------------------------

Jornada de Capacitación para la Gestión del Equipamiento en Bancos de Sangre

Fecha: 8 de Agosto de 2013

Asociación Argentina de Hemoterapia e Inmunohematología
Centro Regional de Hemoterapia, Hospital de Pediatría JP Garrahan


Click aquí para más información

--------------------------------------------------------------------------------------------------------------------------

XIV Congreso Argentino de Medicina Transfusional

El 11, 12 y 13 de septiembre de 2013 se estará desarrollando, en el Centro de Convenciones Paláis Rouge (Jerónimo Salguero 1441, Ciudad de Buenos Aires, República Argentina), el XIV CONGRESO ARGENTINO DE MEDICINA TRANSFUSIONAL, organizado por la AAHI.

Click aquí para más información

--------------------------------------------------------------------------------------------------------------------------


AABB SmartBrief. 23 de julio de 2013

AABB SmartBrief. 22 de julio de 2013


ISBT Kuala Lumpur 2013. Only two weeks until close abstract submission


AABB SmartBrief. 19 de julio de 2013

AABB SmartBrief. 18 de julio de 2013


Noticias de la FMH. 18 de julio de 2013

 

 

Comité de Editorial y Publicaciones – GCIAMT

Hasta la próxima edición.
 
----------------------------------------------------------------------------------------------------------------
Noticias Breves julio 23-2013

 
En esta edición acercamos una breve reseña de la reunión de la Comisión Directiva del GCIAMT realizada a través de las Tecnologías de la Comunicación e Información
 
CONCLUSIONES DE LA SEGUNDA REUNIÓN VIRTUAL DE LA COMISIÓN DIRECTIVA DEL GCIAMT PARA CONOCIMIENTO DE TODOS LOS MIEMBROS DEL GRUPO
 
1.  Personería jurídica aun en trámites. Ya se introdujo el acta constitutiva y estatutos para su debido registro.
 
2. La Dra. Ana del Pozo, trabaja en el foro " Hombres que tienen sexo con hombres". Pronto se dará inicio a esta actividad.
 
3. Actualmente está en proceso la actualización del directorio
 En el actual directorio somos 568 socios. Apenas un poco más de 300  están en la red.
- Se asignaron coordinadores. Agradecemos a todos su colaboración.  Esperamos tener la respuesta antes del 31 de agosto
Coordinadores:
 - Anna Bárbara, Brasil, respondió, aún no ha enviado actualización
-  Ignacio Alurralde, Bolivia: respondió parcialmente
-  Milton Larrondo, Chile. Respondió parcialmente
-  Armando Cortes, Gloria Barco y Sergio Jaramillo.  Colombia: No han enviado la actualización
- Román y Graciela Ochoa. Ecuador.  No han enviado actualización
- Salvador  Oyonarte y Roberto Roig, España: no ha enviado respuesta.
- Inés Zelaya,  Honduras.   Pendiente actualización
 - Rocío Castillo. Envío parcial de actualización
-  Bélgica Moreno. Panamá: pendiente la actualización.
- Oscar Echeverría. Paraguay: pendiente que envíe la actualización
- Ina Pérez, Perú. Pendiente
- Oscar Torres  y Alejandro Chiera: Argentina,  pendiente
-Jorge Curbelo.  Uruguay. En espera de su respuesta
 -Alex Indrikovs.  USA, se ofreció a colaborar, envío parcial
 -Paula, Ariel y Regina. Guatemala. Enviaron directorio actualizado.
República Dominicana, Costa Rica, Nicaragua y El Salvador nunca respondieron el mensaje
 Venezuela. Graciela León y Nelly Vásquez.   87 socios en directorio, se han actualizado 49. Hasta este momento tenemos 260 actualizados en los diferentes países
 
6. Global Healing asumirá el proyecto ALAS, ALAS-GH. ALAS  próximamente pasara a ser socio institucional de GCIAMT. La alianza GH-ALAS-GCIAMT,  puede contribuir a potenciar los proyectos
 
7. Está en proceso proyecto de acreditación, liderado por los Dres. Cruz, Lichtiger y Kuperman,  Se revisan los estándares de OPS, que servirán de marco para este proyecto y una vez adaptados  se entrará en la fase de formación de auditores en toda la región, para lo cual se están gestionando los fondos necesarios.
 
8. En progreso proyecto de investigación epidemiológica, de la mano de la Dra. Esther Sabino. Será un taller con un número aproximado de 10 participantes. Se busca apoyo financiero.
 
9.   Información del Comité de Publicaciones:
-          El 15 de agosto se pondrán en línea la nueva base de Campus Virtual apta para soporte de videoconferencia, y vista en dispositivos móviles. Moodle 12.0 será la versión que además permite una interface al usuario a su conveniencia.
-          El 31 de agosto estará disponible el salón de video conferencias para el GCIAMT por lo que a partir de dicha fecha se podrán realizar las reuniones que en su momento se hacían con auspicio comercial. La primera conferencia la haremos con el Comité de Editorial y Publicaciones para acordar las actividades del último cuatrimestre del 2013.
-           En el mes de agosto -septiembre saldrá el número impreso de nuestro Boletín en la revista Hemasferio: en dicho número se presentarán las memorias del Congreso de Guatemala y las actividades del Congreso de la AAHI en Argentina del mes de Septiembre, además de una reseña del día mundial del Donante de Sangre.
-          A partir del 20 de agosto, aprovechando la capacidad de la nueva base de aula virtual podremos disponer en línea de boletines semanales, cortos y con información que nos proveerán los diferentes miembros del grupo o miembros institucionales.
-          Se está evaluando la posibilidad de realizar una publicación trimestral de e-póster para que los miembros del GCIAMT se animen a publicar sus trabajos de investigación y así construir una cultura de uso del Comité para hacer conocer sus esfuerzos en tal sentido, esto lo definiremos en la Videoconferencia que te comenté probará el sistema en forma internacional.
 
10.  Información del Comité de Educación Continua y continuada:
-          Para agosto  saldrá el primer trabajo de “Cómo lo hacen en…” Con el tema sobre “Selección del Donante”. Este programa está bajo la Coordinación de: Graciela León, César Cérdas y Armando Cortés.
-          Graciela León, Ana del Pozo, Esther Sabino, Oscar Torres y Armando Cortés León formarán parte del Comité Científico Internacional del próximo Congreso del GCIAMT en Minas de Gerais, además de Anna Barbara Proietti y Júnia Cióffi miembros del GCIAMT  y otras personas de Brasil en el Comité Local
-          El libro saldrá en edición digital; se esperan dos cosas; incluir fe de erratas y que GCIAMT tenga vida jurídica para poder comercializar el libro en página Web.
-           El libro de Inmunohematología está en progreso. El 31 de julio finaliza la entrega de capítulos por los autores.
-          En proyecto la creación de revista propia de  GCIAMT.  Armando Cortés, César Cerdas como responsables del mismo.
 

 

                Graciela León                                                   Nelly de Martínez

                 Presidente                                                          Secretaria General

 
 
----------------------------------------------------------------------------------------------------------------
Noticias Breves julio 22-2013

 

MATERIALES COMPARTIDOS POR MIEMBROS DEL GRUPO GCIAMT

 

El  Dr. Oscar Torres nos comparte la siguiente información

 


 
      Only two weeks until close abstract submission
 
The opportunity to submit your abstract for the 24th Regional Congress in Kuala Lumpur will close August 4, 2013 at 23.59 hours CET.
 
Why not take the opportunity to share your scientific work with others by submitting an abstract to the congress. You can do so here before the deadline as mentioned above. Click here for more information on abstract submission.
 
If you need help or review of the structure and language of your abstract, please send an e-mail to the ISBT Central Office. The deadline for this service is Monday July 29, 2013 at 17.00 hours CET.
 
Please click here for more information on abstract submission.
 
Scientific programme
 
 
The ISBT Academy programme includes educational sessions at the Academy day December 1, on transfusion transmitted infectious diseases, donors, quality, haemovigilance, immunohaematology and platelet immunology and an exciting scientific programme which will include three plenary sessions:
1.     It’s all about red cells
2.     It’s all about platelets
3.     It’s all about blood safety
Full details of the programme can be found here.  
 
Our Corporate Partners
 
 
Want to unsubscribe?
You've received this e-mail because you are on the mailinglist of ISBT.
If you no longer wish to receive our newsletter you can send an e-mail to communication@isbtweb.org.
Our contact details
Address: Marnixstraat 317, 1016 TB, Amsterdam, the Netherlands
Web address: www.isbtweb.org/malaysia
Email address: malaysia@isbtweb.org

 

Comité de Editorial y Publicaciones – GCIAMT

Hasta la próxima edición.

-------------------------------------------------------------------------------------------------------
Noticias Breves julio 21-2013

 

MATERIALES COMPARTIDOS POR MIEMBROS DEL GRUPO GCIAMT

 

El  Dr. César Cerdas-Quesada,  Especialista Inmunohematología y Banco de Sangre de la Universidad de Costa Rica nos comporte este alerta:

 

 
Visit aabb.org Unsubscribe to this Newsletter
July 19, 2013 | Vol. 19 | No. 24
 
IN THIS ISSUE
 

AABB Posts 'Questions and Answers' About Recently Revised WNV Testing Recommendations

AABB posted "Questions and Answers" regarding Association Bulletin #13-02 titled "West Nile Virus Nucleic Acid Testing – Revised Recommendations" that was released June 28, 2013. The Q-and-A document offers responses to questions AABB members have posed to the organization and includes the rationale for the revisions, a summary of changes made to previous criteria, and answers related to reporting presumed/potentially viremic or West Nile virus-reactive donations to the AABB West Nile Virus Biovigilance Network. Association Bulletin #13-02, which was announced in this publication, updates recommendations for nucleic acid testing for West Nile virus that appeared in Association Bulletin #08-03, released April 18, 2008.

HHS Publishes 2011 National Blood Collection and Utilization Survey Report

The U.S. Department of Health and Human Services, or HHS, has released the 2011 National Blood Collection and Utilization Survey report, which provides 2011 data on the collection and transfusion of blood, identifies trends and compares current findings with those of previous survey years. According to the report, the supply of available allogeneic whole blood, or WB, and red blood cell, or RBC, units, after accounting for test discards, was nearly 14.5 million units in 2011, which is a statistically significant decrease of 9.1 percent compared with the supply of allogeneic WB and RBCs in 2008. The 2011 report explains that, over the past several years, blood collectors have made adjustments to correct the oversupply of WB and RBCs that was identified in the 2009 survey report. Additionally, transfusions of WB and RBCs declined significantly by 8.2 percent to 13.8 million units. The blood supply was provided by more than 9 million allogeneic donors — 31 percent of whom were first-time donors and 69 percent of whom had donated previously. A total of 20.9 million components were transfused, including WB, RBCs, platelets, plasma, cryoprecipitate and granulocytes, representing a decrease of 11.6 percent compared with transfusions in 2008. Thirty percent of 2011 hospital respondents indicated that patient blood management now is a formal program in their establishments.
The 2011 HHS report, produced by AABB, is available as a free download on the AABB and HHS websites.

Select Presentations From AABB's TRALI Workshop Available to Members

Select presentations from AABB's public workshop on TRALI risk reduction, held July 8, are available to members on the AABB website. This member benefit offers access to 12 slide set presentations by experts — such as Steven Kleinman, MD, and Darrell Triulzi, MD — on topics that include general information, the pathophysiology of TRALI, and considerations for human leukocyte antibody, or HLA, detection. Specific user experiences with platelet additive solutions and reports from facilities that implemented TRALI risk-reduction measures also are covered within the slide sets.

AABB Issues Summary of Significant Changes to the IRL Standards; New Assessment Tools Released

A summary of significant changes to the eighth edition of the Standards for Immunohematology Reference Laboratories, or IRL Standards, is available on the AABB website. Developed by AABB's IRL Standards Program Unit, or IRL SPU, the summary is intended to assist AABB members with implementation of the new IRL Standards and includes the rationale for the revisions appearing in the eighth edition. Additionally, the document offers the IRL SPU's responses to comments received during the 60-day comment period for the Standards. The eighth edition of IRL Standards becomes effective Oct. 1, 2013, and is available for purchase in the AABB Marketplace.
New IRL assessment tools for facilities and assessors also are available on the AABB website. These resources are free for members and are associated with AABB's revised IRL Standards. The facilities tool can help institutions prepare for AABB assessments, while the tool for assessors provides questions applicable to evaluating a facility's compliance with the eighth edition.

CDC No Longer Recommends Use of Exchange Transfusion to Treat Severe Malaria

The U.S. Centers for Disease Control and Prevention announced, on July 15, that the use of exchange transfusion, or ET — as an adjunct to antimalarial drugs — is no longer recommended to treat severe malaria. ET involves removing a portion of blood from the patient and replacing it with uninfected blood; this process was believed to remove toxins and malaria-infected cells. However, past use of the practice was based upon limited evidence. CDC recently analyzed data from the U.S. National Malaria Surveillance System to determine the efficacy of ET as an adjunct treatment and reviewed the relevant available literature. The agency found that outcomes for patients with severe malaria treated with ET did not differ from outcomes for similarly affected patients treated without ET. The CDC concluded the survival of patients with the condition is not strongly associated with ET treatment.

FDA Seeks Comments on Proposed Information Collection Requirements for HCT/Ps

The Food and Drug Administration requested comments on proposed information collection in a "Federal Register" notice dated July 12. The request relates to the establishment registration and listing, donor eligibility (screening and testing), and current good tissue practice regulatory requirements for human cells, tissues, and cellular and tissue-based products, or HCT/Ps. FDA is asking for comments about whether the collection of information is necessary for the proper performance of FDA's functions; the accuracy of FDA's estimate of the time and effort needed for the collection, including the validity of the agency's methodology and assumptions; ways to enhance the quality, utility and clarity of the collected information; and methods that would reduce the burden of collecting information for the respondents. Summaries of the applicable regulatory requirements are available on the AABB website. Comments should be submitted by Sept. 10.

Transfusion News Video Highlights Transfusion-Transmitted Hepatitis B From Donors With Occult Infection

A video posted on the Transfusion News website features two studies on transfusion-transmitted hepatitis B from donors with occult hepatitis B infection, or OBI — defined in an article in the July issue of "Transfusion" as serologically undetectable hepatitis B virus surface antigen, or HBsAg, in spite of the presence of circulating HBV DNA. In their European-based study, featured in this month's "Transfusion," J. Allain and colleagues found that blood products from OBI donors carry a high risk of HBV transfusion transmission that is dependent on the presence of antibody to HBsAg, or anti-HBs, and viral dose. Additionally, the authors indicated that screening for antibodies to HBV core antigen, or anti-HBc, and HBV nucleic acid testing, or NAT, may be a justifiable safety measure, depending on epidemiology.
In the second study, also in the July issue of "Transfusion," R. Taira et al. evaluated the impact of individual-donation NAT, or ID-NAT, on transfusion-transmitted HBV, or TT-HBV, from donors with OBI in Japan. The authors found that 85 percent of TT-HBV infections that arose from OBI donations would have been prevented by ID-NAT. They further noted that ID-NAT showed that 1.94 percent of donations with low anti-HBc and anti-HBs titers were viremic and that there was no correlation between anti-HBc titers and the frequency of viremia. They concluded that "[t]he elimination of all donations with low anti-HBc and anti-HBs titers would be important to any strategy aimed at preventing OBI-related TT-HBV infections in countries … that have a slightly elevated HBV prevalence in blood donations."
In an editorial in the issue, C. Bianco and R. Dodd state that "[t]he issue that we are still confronting with OBI is that we do not know its actual prevalence among blood donors and its contribution to the residual risk of [TT-HBV] in most regions of the world." They caution that the present studies "contain suggestions that are applicable to the authors' settings, but cannot be comfortably generalized and do not allow construction of clear protocols for donor screening applicable everywhere because of the wide differences in burden of infection and disease in many countries."

AABB Offers Free Shipping on All AABB Marketplace Publications Through July 31

AABB is offering free shipping through 5 pm EDT on Wednesday, July 31, on all publications purchased through its Marketplace. The promotion is open to residents of the U.S., Canada and Mexico; members also receive discounted pricing on the publications, which include the Platelet Transfusion Therapy and the sixth edition of the Standards for Cellular Therapy Services.

AABB Supports Music-Centered Cancer Nonprofit at Annual Meeting & CTTXPO

During its 2013 Annual Meeting and CTTXPO, AABB will be supporting the international, music-centered cancer nonprofit Love Hope Strength, or LHS, whose mission is to save lives via the state-of-the-art medical tools and knowledge that oncology specialists already possess and use in their current practices. The organization builds and supports cancer centers around the globe, raises awareness about cancer needs, and encourages participation in international bone marrow databases through its "Get on the List Campaign." Funds raised from concerts held in various countries have enabled LHS to purchase the first mammography and brachytherapy machines for Nepal, fund a mobile cancer unit that will screen and treat 20,000-30,000 patients per year in remote regions of Peru, and finance a transport vehicle for a children's cancer center in New Jersey. AABB encourages attendees of the 2013 AABB Annual Meeting & CTTXPO to make a donation when registering online for this meeting. Donations to the Love Hope Strength Foundation will help defray the costs of necessary medical technology and services that enhance cancer care at home and abroad.

Reminder: Individuals Encouraged to Participate in NBF Golf Tournament, 5K Run for Research and 1-Mile Walk at Annual Meeting

In conjunction with the 2013 AABB Annual Meeting & CTTXPO in Denver, the National Blood Foundation will host two events to benefit its Scientific Research Grants Program. The 17th Annual NBF Golf Tournament and Challenge Cup is scheduled for Friday, Oct. 11, and will be held at the Fossil Trace Golf Club in Denver. Register to compete for the Challenge Cup and network with friends and colleagues while in the foothills of the Rocky Mountains. Sign up individually or register a foursome.
The 15th Annual NBF 5K Run for Research/1-Mile Walk will be held Sunday, Oct. 13, within walking distance of the Colorado Convention Center. Runners and walkers can enjoy spirited exercise before attending Annual Meeting sessions. Breakfast and a T-shirt are included in the registration fee. Individuals can sign up for this event by completing the Additional Fee Events section of the Annual Meeting registration form or register separately for the event. At the request of previous years' participants, runners will have the opportunity to raise additional funds for NBF through personalized fundraising — the registration confirmation email will contain information to assist in the creation of a fundraising Web page for the purposes of sharing with colleagues and friends.
NBF's Scientific Research Grants Program provides funding for scientific research in the field of transfusion medicine and cellular therapies and supports educational initiatives to help optimize patient and donor care and safety.
For more information about these events or the grants program, contact Amy Quiggins, NBF manager, at +1.301.215.6551 or via email.

Region Watch

According to the National Blood Exchange, the demand for some frozen products, such as type B and type AB plasma and single-bag cryoprecipitate, exceeds national availability; several days are required to fulfill all requests. Levels of O-negative red blood cells, or RBCs, also are too low to meet all known needs. Supplies of other frozen products and RBCs are robust, and platelet products are plentiful nationwide amid low usage.
AABB, 8101 Glenbrook Road, Bethesda, MD 20814
+1.301.907.6977
Managing Editor: Jennifer Garfinkel
Copyright 2013 AABB. All rights reserved.
 
 

Event Calendar

July 24 — AABB Audioconference: Most Common Citations From AABB/CAP read more »
July 31 — AABB Audioconference: Factors That Regulate Red Cell Alloimmunization — Lessons From Animal Models
read more »
August 6 — AABB Audioconference: Project Management 101 for Transfusion Medicine — Tools and Practices
read more »
August 7 — AABB Audioconference: Using Common Applications for Training and Change Tracking read more »
August 8 — AABB Webinar: Coagulation Management
read more »
August 20 — AABB Webinar: Approaches to Cleaning, Disinfection and Validation for Cellular Therapy Facilities
 read more »
August 21 — AABB Audioconference: Toolbox of Quality Improvement — What Can Everyone Do to Improve Quality read more »
September 8-14 — Blood Collectors Week read more »
Full Calendar read more »

New Web Resources

FDA Clears SynGen Inc.'s Cord Blood Processing Device read more »
 
 
 

CONGRESO INTERNACIONAL HEMOFILIA, ENFERMEDADES HEMORRÁGICAS, TROMBOSIS DEL GRUPO CARS (GRUPO CENTROAMERICANO DE ESTUDIO E INVESTIGACIÓN EN HEMOFILIA

 

La Dra. Marta Navarrete Durán, Pediatra – Hematóloga Jefe del Servicio de Hematología del Hospital Nacional de Niños “Dr. Carlos Sáenz Herrera”, San José, Costa Rica, nos invita a difundir y participar de este Congreso en el que se incluyeron tópicos relacionados con la transfusión sanguínea con la intención de ampliar el conocimiento sobre el particular para que se refleje en la atención de sus pacientes.

Para ingresar a la información utilice el siguiente link:  

 


 CAMBIO DE DOMINIO DE BIOLINKER EN ARGENTINA

 

A partir de Junio 2013 y paralelamente al cambio del nombre de la empresa todos las direcciones de correo del dominio @biolinker.com.ar pasaran a cambiar al nuevo dominio @alere.com.ar.  ALERE S.A.  (Continuadora de Biolinker SA)

 

 

Comité de Editorial y Publicaciones – GCIAMT

Hasta la próxima edición.
 -------------------------------------------------------------------------------------------------------------------
Noticias Breves julio 20-2013
 
MATERIALES COMPARTIDOS POR MIEMBROS DEL GRUPO GCIAMT
 
El  Dr. César Cerdas-Quesada,  Especialista Inmunohematología y Banco de Sangre de la Universidad de Costa Rica nos comporte este alerta:



Impact Factor (2012): 1.858
Dear Reader of Blood Transfusion,
You are receiving this e-mail when new articles of BT are published online at www.bloodtransfusion.it.
You may unsubscribe to this free alert service at any time by using the links at the bottom of this page.
 
Latest articles available online ahead of print
Turning severe into moderate haemophilia by prophylaxis: are we reaching our goal?
Ingrid den Uijl, Douwe Biesma, Diederick Grobbee, Kathelijn Fischer
ABSTRACT     PDF     Published online: 06/11/2012

Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation
Paolo Perazzo, Marco Viganò, Laura de Girolamo, Francesco Verde, Anna Vinci, Giuseppe Banfi, Sergio Romagnoli
ABSTRACT     PDF     Published online: 07/05/2013

The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm
Francesco Bennardello, Carmelo Fidone, Vincenzo Spadola, Sergio Cabibbo, Simone Travali, Giovanni Garozzo, Agostino Antolino, Giuseppe Tavolino, Cadigia Falla, Pietro Bonomo
ABSTRACT     PDF     Published online: 21/05/2013

A severe haemolytic transfusion reaction caused by anti-Lea active at 37 °C
Petter Höglund, Ragnhild Rosengren-Lindquist, Agneta Taune Wikman
ABSTRACT     PDF     Published online: 21/12/2012

Experience in the evaluation of foeto-maternal haemorrhage by flow cytometry
Pier Luigi Tazzari, Francesca Ricci, Silvia Manfroi, Pasqualepaolo Pagliaro
ABSTRACT     PDF     Published online: 10/10/2012

Evaluation of ABO blood groups as a risk factor for myocardial infarction
Irena Jukic, Jasna Bingulac-Popovic, Vesna Dogic, Ana Hecimovic, Ivana Babic, Ivanka Batarilo, Cedomir Maglov, Deana Sturm
ABSTRACT     PDF     Published online: 29/10/2012
 
Latest articles in print issue

Blood Transfusion - 3 2013  (Pages 321-480)

Is my blood mine? Some comments on the Convention on Human Rights and Biomedicine (Pages 321-323)
Carlo Petrini
ABSTRACT      PDF     FULLTEXT     Published online: 12/09/2012

Blood donation and the policies of solidarity (Pages 324-326)
Salvatore Veca
ABSTRACT      PDF     FULLTEXT     Published online: 21/02/2013

Target of prophylaxis in severe haemophilia: more than factor levels (Pages 327-329)
Antonio Coppola, Massimo Franchini
ABSTRACT      PDF     FULLTEXT     Published online: 21/12/2012

High-risk anaemic Jehovah's Witness patients should be managed in the intensive care unit (Pages 330-332)
Andrei M. Beliaev
ABSTRACT      PDF     FULLTEXT     Published online: 19/03/2013

Preoperative autologous blood donation in lower limb arthroplasty surgery: has the time come for its retirement? (Pages 333-336)
Manuel Muñoz, José A. García-Erce
ABSTRACT      PDF     FULLTEXT     Published online: 07/05/2013

Infusible platelet membrane as a platelet substitute for transfusion: an overview (Pages 337-342)
Saleh Nasiri
ABSTRACT      PDF     FULLTEXT     Published online: 14/05/2013

Current methods for the reduction of blood-borne pathogens: a comprehensive literature review (Pages 343-348)
Susanne M. Picker
ABSTRACT      PDF     FULLTEXT     Published online: 14/03/2013

Antiplatelet agents in clinical practice and their haemorrhagic risk (Pages 349-356)
Paolo Gresele
ABSTRACT      PDF     FULLTEXT     Published online: 09/05/2013

T-regulatory cell-mediated immune tolerance as a potential immunotherapeutic strategy to facilitate graft survival (Pages 357-363)
Mohammad A. Khan, Sana Moeez, Suhail Akhtar
ABSTRACT      PDF     FULLTEXT     Published online: 07/05/2013

Turning severe into moderate haemophilia by prophylaxis: are we reaching our goal?
Ingrid den Uijl, Douwe Biesma, Diederick Grobbee, Kathelijn Fischer
ABSTRACT      PDF     FULLTEXT     Published online: 06/11/2012

Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation (Pages 370-376)
Paolo Perazzo, Marco Viganò, Laura de Girolamo, Francesco Verde, Anna Vinci, Giuseppe Banfi, Sergio Romagnoli
ABSTRACT      PDF     FULLTEXT     Published online: 07/05/2013

The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm (Pages 377-384)
Francesco Bennardello, Carmelo Fidone, Vincenzo Spadola, Sergio Cabibbo, Simone Travali, Giovanni Garozzo, Agostino Antolino, Giuseppe Tavolino, Cadigia Falla, Pietro Bonomo
ABSTRACT      PDF     FULLTEXT     Published online: 21/05/2013

Evaluation of the validity of a rapid method for measuring high and low haemoglobin levels in whole blood donors (Pages 385-390)
Hayedeh J. Shahshahani, Nahid Meraat, Fatemeh Mansouri
ABSTRACT      PDF     FULLTEXT     Published online: 10/10/2012

Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates (Pages 391-399)
Carolina Caballo, Gines Escolar, Maribel Diaz-Ricart, Irene Lopez-Vílchez, Miguel Lozano, Joan Cid, Marcos Pino, Joan Beltrán, Misericordia Basora, Arturo Pereira, Ana M. Galan
ABSTRACT      PDF     FULLTEXT     Published online: 19/09/2012

Six hours of resting platelet concentrates stored at 22-24 ºC for 48 hours in permeable bags preserved pH, swirling and lactate dehydrogenase better and caused less platelet activation (Pages 400-404)
Hossin T. Naghadeh, Bahram A. Badlou, Ali S. Ferizhandy, Tabatabai S. Mohammadreza, Vaeli Shahram
ABSTRACT      PDF     FULLTEXT     Published online: 29/10/2012

Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study (Pages 405-411)
Pilar Solves, Dolores Planelles, Vicente Mirabet, Amando Blanquer, Francisco Carbonell-Uberos
ABSTRACT      PDF     FULLTEXT     Published online: 12/09/2012

Effect of haematocrit on fibrin-based clot firmness in the FIBTEM test (Pages 412-418)
Cristina Solomon, Niels Rahe-Meyer, Herbert Schöchl, Marco Ranucci, Klaus Görlinger
ABSTRACT      PDF     FULLTEXT     Published online: 20/11/2012

The effect of maximum storage on iron status, oxidative stress and antioxidant protection in paediatric packed cell units (Pages 419-425)
Keith Collard, Desley White, Adrian Copplestone
ABSTRACT      PDF     FULLTEXT     Published online: 12/09/2012

Limited utility of algorithms predicting blood transfusions (Pages 426-432)
Ralf Karger, Andrea Bornmann, Volker Kretschmer
ABSTRACT      PDF     FULLTEXT     Published online: 29/10/2012

Product recall - a Croatian experience (2000-2010) (Pages 433-440)
Tomislav Vuk, Marijan Barišic, Julijana Ljubicic, Ana Hecimovic, Nina Jurakovic-Loncar, Dorotea Šarlija, Irena Jukic
ABSTRACT      PDF     FULLTEXT     Published online: 10/10/2012

Changing blood donor screening criteria from permanent deferral for men who have sex with men to individual sexual risk assessment: no evidence of a significant impact on the human immunodeficiency virus epidemic in Italy (Pages 441-448)
Barbara Suligoi, Simonetta Pupella, Vincenza Regine, Mariangela Raimondo, Claudio Velati, Giuliano Grazzini
ABSTRACT      PDF     FULLTEXT     Published online: 14/06/2013

A simple approach to confirm the presence of anti-D in sera with presumed anti-D+C specificity (Pages 449-451)
Fátima Baía, Eduardo Muñiz-Diaz, Neus Boto, Marta Salgado, Rosa Montero, Teresa Ventura, Helena Sousa, Branca Alves, Núria Nogués, Carmen Koch
ABSTRACT      PDF     FULLTEXT     Published online: 23/01/2013

Supportive treatment of severe anaemia in a Jehovah's Witness with severe trauma (Pages 452-453)
Kristian Lorentzen, Bjarne Kjær, Jørgen Jørgensen
ABSTRACT      PDF     FULLTEXT     Published online: 19/03/2013

The second example of anti-Erb in a woman during her third pregnancy (Pages 454-455)
Raul Cordoba, Joyce Poole, Imelda Marais, Asuncion Mora, Luis Ercoreca, Shannon Long
ABSTRACT      PDF     FULLTEXT     Published online: 10/10/2012

A severe haemolytic transfusion reaction caused by anti-Lea active at 37 °C (Pages 456-459)
Petter Höglund, Ragnhild Rosengren-Lindquist, Agneta T. Wikman
ABSTRACT      PDF     FULLTEXT     Published online: 21/12/2012

Blood group Aint causing uncertainty during organ donor work-up for incompatible (A2-O) liver transplantation (Pages 460-461)
Deepti Sachan
ABSTRACT      PDF     FULLTEXT     Published online: 11/10/2012

Experience in the evaluation of foeto-maternal haemorrhage by flow cytometry (Pages 462-463)
Pier Luigi Tazzari, Francesca Ricci, Silvia Manfroi, Pasqualepaolo Pagliaro
ABSTRACT      PDF     FULLTEXT     Published online: 10/10/2012

Evaluation of ABO blood groups as a risk factor for myocardial infarction (Pages 464-465)
Irena Jukic, Jasna Bingulac-Popovic, Vesna Dogic, Ana Hecimovic, Ivana Babic, Ivanka Batarilo, Cedomir Maglov, Deana Sturm
ABSTRACT      PDF     FULLTEXT     Published online: 29/10/2012

Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia (Pages 466-468)
Pavol Hollý, Lenka Lisá, Ivana Plamenová, Miroslava Dobrotová, Peter Kubisz
ABSTRACT      PDF     FULLTEXT     Published online: 06/12/2012

Reproductive care in human immunodeficiency virus serodiscordant couples with haemophilia (Pages 469-470)
Isabella Garagiola, Mimosa Mortarino, Augusto Enrico Semprini, Flora Peyvandi
ABSTRACT      PDF     FULLTEXT     Published online: 13/09/2012

Different signal-to-cut-off ratios from three automated anti-hepatitis C virus chemiluminescence immunoassays in relation to results of recombinant immunoblot assays and nucleic acid testing (Pages 471-473)
Eun-Jee Oh, Jiyoung Chang, Jin-Young Yang, Yonggoo Kim, Yeon-Joon Park, Kyungja Han
ABSTRACT      PDF     FULLTEXT     Published online: 20/11/2012

Surface arthroplasty increases blood loss and transfusion requirement in comparison with conventional total hip replacement (Pages 474-476)
Dario Regis, Andrea Sandri, Elena Sambugaro, Massimo Franchini
ABSTRACT      PDF     FULLTEXT     Published online: 23/01/2013

Thrombocytopenia in patients with patent ductus arteriosus after transcatheter closure: perilous complication or harmless incidental finding? (Pages 477-478)
Boting Wu, Ruiming Rong
ABSTRACT      PDF     FULLTEXT     Published online: 29/10/2012

Book review (Pages 479)
Giancarlo M. Liumbruno
ABSTRACT      PDF     FULLTEXT     Published online: 19/06/2013

Gemino Fiorelli (Pages 480)
Claudio Velati
ABSTRACT      PDF     FULLTEXT     Published online: 19/06/2013
 
MATERIALES DISPONIBLES
Les recordamos que pueden acceder en el aula virtual a la Consulta al experto del mes de julio que organiza, coordina y distribuye el Comité de Educación Continua y Continuada del GCIAMT en la persona del Dr. Armando Cortés.
Invitamos a todos acceder a través del     (Recurso) Consulta al experto del mes de julio de 2013. Seguridad Transfusional  y  el foro:    (Foro) Intercambio de Comentarios Consulta al Experto. En este mes podrán leer y descargar el artículo sobre Seguridad Transfusional como así también los comentarios que ya hicieran algunos miembros del Grupo. Recordamos que se requiere clave de acceso si no dispone de ella o no la recuerda, por favor, solicite la misma a boletingciamt@gmail.com. Muchas gracias.
 
 
DÍA DEL AMIGO EN ARGENTINA, URUGUAY y BRASIL

Si bien este día se festeja en diferentes fechas en otros países, queremos en esta fecha recordar al Odontólogo argentino, profesor de filosofía e historia, músico y miembro del Rotary Club, quien propuso festejar el Día del Amigo el 20 de julio de 1969. Dicho día Neil Armstrong posaba su pie izquierdo en la luna y, él, consideró que podría ser un momento especial para que los seres humanos se reunieran en torno de un culto esencial que es la amistad.
Saludamos a todos los miembros del GCIAMT, independientemente del país en el que se encuentren porque no sólo compartimos una profesión, un quehacer cotidiano, un proyecto científico, sino que cultivamos una profunda amistad y para ello sólo basta recordar nuestros encuentros en los diferentes congresos, jornadas, talleres, cursos y actividades científicas que nos convocan y nos reúne.
 Feliz día para todos.
 
Prof. Dr. José Magariños
Comité Editorial y Publicaciones GCIAMT

 
CURSO SOBRE EL ROL DEL INMUONENSAYO DE LA FACULTAD DE FARMACIA Y BIOQUÍMICA – UNIVERSIDAD DE BUENOS AIRES

 
 
 
 
-------------------------------------------------------------------------------------------------------------------
Noticias Breves julio 19-2013

 

MATERIALES DISPONIBLES


Les recordamos que pueden acceder libremente al archivo de la Biblioteca Virtual que produce, distribuye y coordina el Comité de Educación Continua y Continuada del GCIAMT en la persona del Dr. Armando Cortés.

Invitamos a todos acceder a través del BIBLIOTECA VIRTUAL DEL GCIAMT - Artículos seleccionados  y en este mes podrán leer y descargar artículos acerca del tema Transfusión  y Cirugía Cardíaca.

 
SISTEMA DE VIDEOCONFERENCIAS


Nos complace en informar que durante el mes de agosto próximo estaremos realizando las últimas pruebas a nivel internacional para el uso de un sistema de videoconferencia para beneficio de los miembros del GCIAMT.

De esta forma nuevamente dispondremos de una herramienta con un enorme potencial para la interacción, capacitación y formación de todos los miembros del GCIAMT.
 
Agradezco una vez más al Instituto del Profesorado en Enfermería Padre Luis Tezza a través de sus autoridades de la Congregación Hijas de San Camilo el espacio para difundir, almacenar y utilizar el aula virtual de la organización en forma libre y gratuita y ahora el servicio de videoconferencia que estaremos inaugurando próximamente.

Prof. Dr. José Magariños
Comité Editorial y Publicaciones GCIAMT


La Asociación Argentina de Hemoterapia e Inmunohematología nos informó:

 

Evento Educacional Ortho ON Demand: Julio 2013
Estimado Profesional de la Medicina de la Transfusión,
Ortho ON DEMAND (www.OrthoONDEMAND.com) es una plataforma educacional virtual innovadora que le permite a los profesionales de los centros de donación, de los bancos de sangre y de los servicios de transfusión, aprender y conectarse con expertos mundiales en Medicina de Transfusión de los temas importantes para el logro de la seguridad y eficiencia en el banco de sangre, basados en la ciencia. La plataforma incorpora numerosos recursos para aquellos que buscan aumentar sus conocimientos y hacer nuevas conexiones relacionadas con la Medicina Transfusional.
De antemano gracias por participar in la experiencia virtual Ortho ON DEMAND. No olvide registrarse para nuestro próximo evento el 25 de Julio de  2013,de 1 - 2 PM EDT (Horario del Este).  Lo invitamos a conectarse con expertos de la Medicina Transfusional en temas interesantes como el de Liderazgo y Cambio.

La presentación del evento en vivo de Julio 25 será:

Liderazgo y Cambio: El Lado Humano del Cambio
Presentado por: Eva D. Quinley, MS, MT(ASCP)SBB, Vice Presidente Senior, Calidad & Asuntos Regulatorios, Centro de Sangre de New York.
·         Cómo la gente reacciona a los cambios y por qué son resistentes a ellos?
·         Las cualidades de un buen líder de cambio
·         Lo que se necesita para lograr el cambio

Participe en la sesión en vivo de Preguntas & Respuestas con el experto después de la presentación
 
Regístrese ahora para el evento en vivo el 25 de Julio de 2013, 1 PM EDT (Horario del Este).
 
-Equipo Ortho ON DEMAND

 

 

 ---------------------------------------------------------------------------------------------------------------------
Noticias Breves julio 17-2013

PRÓXIMOS EVENTOS

 

Curso: “Actualización en Inmunohematología”

Jueves 1, 15, 22, y 29 de agosto de 2013

18 a 21 hs.

Disertantes:

Dr. Oscar Torres.

Presidente de la Asociación Argentina de Hemoterapia e Inmunohematología. Jefe de la Unidad de Hemoterapia HMIR Sardá. Docente Adscripto Departamento de Microbiología, Facultad de Medicina, UBA.

 Dr. Oscar Canle

Unidad de Hemoterapia, Hospital de Niños Dr. Ricardo Gutierrez

Servicio de Medicina Transfusional Sanatorio Mater Dei

 THeI. Carlos Rey

Dirección Técnica. Centro de Referencia Inmunohematológico e Bs. As. Supervision Técnica, Departamento de Hemoterapia e Inmnohematología. Sección Inmunohematología. Hospital de Clínicas “D. J. de S. Martín”. Jefatura de Trabajos Prácticos Curso de Técnicos en Hemoterrapia e Inmunohematología. Facultad de Medicina. UBA.

 

THeI. Graciela Deutsch

Dirección Técnica. Centro de Referencia Inmunohematológico e Bs. As. Supervision Técnica, Departamento de Hemoterapia e Inmnohematología. Sección Inmunohematología.. Hospital de Clínicas “D. J. de S. Martín”. Jefatura de Trabajos Prácticos Curso de Técnicos en Hemoterrapia e Inmunohematología. Facultad de Medicina. UBA.

 Dr. Carlos A. González

Investigador Principal. Hospital F. J. Muñiz. CABA

 Sede del Curso:

El curso se dictará en Fundación Hemocentro Buenos Aires.

Dirección: Av. Díaz Vélez 3973 - CABA

 Costo de inscripción:

Médicos,  Bioquímicos, Biólogos: 150 pesos argentinos

Técnicos y estudiantes: 100 pesos argentinos

 

El material bibliográfico se encontrará disponible en la página de la Fundación Hemocentro Buenos Aires después de cada disertación. El cupo es limitado y la inscripción puede realizarse arecepción@hemobaires.org.ar o al teléfono 4981-5020

Se entregarán Certificados de Asistencia a los participantes que hayan concurrido al 75% de las clases.

 Más información y Programa del curso enhttp://www.hemobaires.org.ar/docencia_nota.php?id=29

 Nota: El día jueves 8 de Agosto no habrá clases

 

CURSO INTERNACIONAL de la SPIBST




 

-- -------------------------------------------------------------------------------------------------------------



Noticias Breves julio 15-2013


 


PRÓXIMOS EVENTOS


 


Viernes 23 de Agosto 2013



Obra Social del Personal Docente
Servicio de Medicina Transfusional | Director: Dr. Oscar López

Autoinmunidad | Discusión de casos clínicos AHAI.
Diserta: Lic. Marcelo Russo | Gerente de Productos DiaMed Argentina S.A.

Dentro del vasto repertorio de entidades clínicas que asiste la Medicina Transfusional, se hallan las patologías autoinmunes que afectan la economía propia de células de la sangre, sobre todo los eritrocitos y las plaquetas.
El sistema inmune que ha evolucionado en su respuesta adaptativa no está libre de averías y entonces en algunas ocasiones nuestros propios anticuerpos son capaces de reaccionar contra nuestras propias células.
En muchas ocasiones los pacientes con actividad autoinmune requerirán transfusiones de hematíes o plaquetas, es allí cuando asistimos a interpretaciones especiales en las pruebas pretransfusionales.
Discutiremos en este encuentro, la tecnología aplicada al diagnóstico y las posibles vías de solución de diferentes interrogantes a propósito de ciertos casos clínicos.

Conferencia y taller | Sin arancel | Inicio 14:00 horas
Consultas vía MSN: 1141990224 o 53173561 |
Lavalle 1973 Auditorio 8° Piso. CABA






XIV Congreso Argentino de Medicina Transfusional (actualización 06-2013)


 


El 11, 12 y 13 de septiembre de 2013 se estará desarrollando, en el Centro de Convenciones Paláis Rouge (Jerónimo Salguero 1441, Ciudad de Buenos Aires, República Argentina), el XIV CONGRESO ARGENTINO DE MEDICINA TRANSFUSIONAL, organizado por la AAHI.

Click aquí para acceder al Programa Científico

 

Octubre – Noviembre 2013

Os recordamos que desde el día 1 de octubre y hasta el 30 de noviembre tendrá lugar el curso online "Transfusión en situaciones especiales".

El curso va dirigido a Médicos residentes de hematología, a hematólogos interesados en adquirir o profundizar los conocimientos en la transfusión en situaciones especiales, a los profesionales sanitarios que desarrollan su actividad en la práctica transfusional y a médicos de otras especialidades.

Accede fácilmente al programa clicando AQUI o bien puedes descargártelo de la página web www.sets.es.

Cordiales saludos,


Sandra Módenes
Secretaria Técnica SETS


 

--

Prof. Dr. José Magariños
Comité Editorial y Publicaciones GCIAMT

No hay comentarios:

Publicar un comentario

Suscribirse a: Entradas (Atom)